Healthequity Inc (NASDAQ:HQY) – Equities research analysts at Cantor Fitzgerald upped their FY2019 earnings per share estimates for shares of Healthequity in a research report issued to clients and investors on Wednesday. Cantor Fitzgerald analyst S. Halper now anticipates that the company will post earnings of $1.00 per share for the year, up from their previous forecast of $0.90. Cantor Fitzgerald has a “Overweight” rating and a $60.00 price objective on the stock.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.04. The company had revenue of $56.80 million for the quarter, compared to the consensus estimate of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm’s quarterly revenue was up 31.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.10 EPS.

HQY has been the topic of a number of other research reports. Robert W. Baird increased their price target on Healthequity from $48.00 to $49.00 and gave the company a “neutral” rating in a research note on Wednesday. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research note on Tuesday, November 7th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $57.00 price target on the stock in a research note on Saturday. Citigroup assumed coverage on Healthequity in a research note on Thursday, January 4th. They issued a “buy” rating on the stock. Finally, Chardan Capital increased their price target on Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research note on Wednesday, December 6th. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $56.67.

Healthequity (NASDAQ HQY) opened at $51.29 on Friday. The firm has a market capitalization of $3,111.92, a price-to-earnings ratio of 73.27, a PEG ratio of 1.90 and a beta of 1.70. Healthequity has a 12 month low of $37.62 and a 12 month high of $55.31.

Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in Healthequity by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock worth $211,145,000 after purchasing an additional 122,061 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Healthequity by 25.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock worth $23,591,000 after purchasing an additional 95,514 shares in the last quarter. Royal Bank of Canada increased its holdings in Healthequity by 42.9% during the 2nd quarter. Royal Bank of Canada now owns 263,778 shares of the company’s stock worth $13,145,000 after purchasing an additional 79,144 shares in the last quarter. New York State Teachers Retirement System increased its holdings in Healthequity by 8.0% during the 3rd quarter. New York State Teachers Retirement System now owns 33,651 shares of the company’s stock worth $1,702,000 after purchasing an additional 2,500 shares in the last quarter. Finally, Sanders Morris Harris LLC bought a new position in Healthequity during the 3rd quarter worth about $2,301,000. Hedge funds and other institutional investors own 98.20% of the company’s stock.

In related news, Director Frank Medici sold 700 shares of the firm’s stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $51.05, for a total transaction of $35,735.00. Following the sale, the director now owns 6,381 shares of the company’s stock, valued at approximately $325,750.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Delano Ladd sold 26,405 shares of the firm’s stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $43.32, for a total value of $1,143,864.60. Following the sale, the executive vice president now directly owns 16,692 shares in the company, valued at approximately $723,097.44. The disclosure for this sale can be found here. Insiders have sold a total of 371,426 shares of company stock worth $18,749,703 in the last ninety days. 29.00% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: “Cantor Fitzgerald Weighs in on Healthequity Inc’s FY2019 Earnings (HQY)” was posted by Watch List News and is the property of of Watch List News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.watchlistnews.com/cantor-fitzgerald-weighs-in-on-healthequity-incs-fy2019-earnings-hqy/1859042.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.